First Time Loading...

Evaxion Biotech A/S
NASDAQ:EVAX

Watchlist Manager
Evaxion Biotech A/S Logo
Evaxion Biotech A/S
NASDAQ:EVAX
Watchlist
Price: 3.9092 USD -0.02%
Updated: May 7, 2024

Evaxion Biotech A/S
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Evaxion Biotech A/S
Cash from Financing Activities Peer Comparison

Comparables:
GMAB
ZEAL
ASND
B
BAVA
BIOPOR

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Evaxion Biotech A/S
NASDAQ:EVAX
Cash from Financing Activities
$10.7m
CAGR 3-Years
7%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Genmab A/S
CSE:GMAB
Cash from Financing Activities
-kr606m
CAGR 3-Years
N/A
CAGR 5-Years
-54%
CAGR 10-Years
N/A
Zealand Pharma A/S
CSE:ZEAL
Cash from Financing Activities
kr907m
CAGR 3-Years
6%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ascendis Pharma A/S
NASDAQ:ASND
Cash from Financing Activities
€135m
CAGR 3-Years
-39%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
B
Bavarian Nordic A/S
CSE:BAVA
Cash from Financing Activities
kr735.8m
CAGR 3-Years
-18%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Bioporto A/S
CSE:BIOPOR
Cash from Financing Activities
kr40.8m
CAGR 3-Years
-32%
CAGR 5-Years
1%
CAGR 10-Years
-2%

See Also

What is Evaxion Biotech A/S's Cash from Financing Activities?
Cash from Financing Activities
10.7m USD

Based on the financial report for Dec 31, 2023, Evaxion Biotech A/S's Cash from Financing Activities amounts to 10.7m USD.

What is Evaxion Biotech A/S's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
3%

Over the last year, the Cash from Financing Activities growth was 36%. The average annual Cash from Financing Activities growth rates for Evaxion Biotech A/S have been 7% over the past three years , 3% over the past five years .